| [1] |
Yuen KCJ, Blevins LS Jr, Findling JW. Important ma-nagement considerations in patients with pituitary disorders during the time of the Covid-19 pandemic[J]. Endocr Pract, 2020, 26(8): 915-922.
doi: 10.4158/EP-2020-0308
URL
|
| [2] |
Fleseriu M, Dekkers OM, Karavitaki N. Endocrinology in the time of COVID-19: management of pituitary tumours[J]. Eur J Endocrinol, 2020, 183(1): G17-G23.
doi: 10.1530/EJE-20-0473
URL
|
| [3] |
Fleseriu M, Buchfelder M, Cetas JS, et al. Pituitary Society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective[J]. Pituitary, 2020, 23(4): 327-337.
doi: 10.1007/s11102-020-01059-7
pmid: 32556793
|
| [4] |
Christ-Crain M, Hoorn EJ, Sherlock M, et al. Endocrinology in the time of COVID-19: management of diabetes insipidus and hyponatraemia[J]. Eur J Endocrinol, 2020, 183(1): G9-G15.
doi: 10.1530/EJE-20-0338
URL
|
| [5] |
Christ-Crain M, Hoorn EJ, Sherlock M, et al. Endocrinology in the time of COVID-19-2021 updates: the management of diabetes insipidus and hyponatraemia[J]. Eur J Endocrinol, 2021, 185(4): G35-G42.
doi: 10.1530/EJE-21-0596
pmid: 34292875
|
| [6] |
中华医学会内分泌学分会. 肢端肥大症诊治中国专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9): 751-760.
|
| [7] |
中国垂体腺瘤协作组. 中国肢端肥大症诊治共识(2021版)[J]. 中华医学杂志, 2021, 101(27): 2115-2126.
|
| [8] |
中国垂体腺瘤协作组. 中国库欣病诊治专家共识(2015)[J]. 中华医学杂志, 2016, 96(11): 835-840.
|
| [9] |
Isidori AM, Arnaldi G, Boscaro M, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency[J]. J Endocrinol Invest, 2020, 43(8): 1141-1147.
doi: 10.1007/s40618-020-01266-w
pmid: 32335855
|
| [10] |
Arlt W, Baldeweg SE, Pearce SHS, et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency[J]. Eur J Endocrinol, 2020, 183(1): G25-G32.
doi: 10.1530/EJE-20-0361
URL
|
| [11] |
Pal R, Joshi A, Bhadada SK, et al. Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence[J]. Endocr Pract, 2022, 28(4): 425-432.
doi: 10.1016/j.eprac.2022.02.003
URL
|
| [12] |
中华医学会内分泌学分会肥胖学组. 肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J]. 中华内分泌代谢杂志, 2022, 38(1): 1-6.
|
| [13] |
Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini-review[J]. Endocrinology, 2022, 163(1):bqab203.
doi: 10.1210/endocr/bqab203
URL
|
| [14] |
Tan T, Khoo B, Mills EG, et al. Association between high serum total cortisol concentrations and mortality from COVID-19[J]. Lancet Diabetes Endocrinol, 2020, 8(8): 659-660.
doi: 10.1016/S2213-8587(20)30216-3
URL
|
| [15] |
Tan T, Khoo B, Mills EG, et al. Cortisol concentrations and mortality from COVID-19 - authors’ reply[J]. Lancet Diabetes Endocrinol, 2020, 8(10):809-810.
|
| [16] |
Pivonello R, Ferrigno R, Isidori AM, et al. COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess[J]. Lancet Diabetes Endocrinol, 2020, 8(8): 654-656.
doi: 10.1016/S2213-8587(20)30215-1
URL
|
| [17] |
Newell-Price J, Nieman LK, Reincke M, et al. Endocrinology in the time of COVID-19: management of Cushing’s syndrome[J]. Eur J Endocrinol, 2020, 183(1): G1-G7.
doi: 10.1530/EJE-20-0352
URL
|
| [18] |
王卫庆, 单忠艳, 王广, 等. 新型冠状病毒肺炎疫情期间糖尿病基层管理专家建议[J]. 中华内分泌代谢杂志, 2020, 36(3): 185-190.
|
| [19] |
中国医师协会内分泌代谢科医师分会, 中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1): 1-10.
|
| [20] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398.
|
